Browse > Article
http://dx.doi.org/10.15324/kjcls.2021.53.2.174

Working Conditions that Impact the Workload of Cytotechnologists: A Study Calculating the Actual Man Power Required  

Jee, Soo Il (Department of Pathology, National Health Insurance Service Ilsan Hospital)
Ahn, Yong Ho (Department of Clinical Laboratory Science, Dongnam Health University)
Ha, Hwa-Jeong (Department of Pathology, Korea Cancer Center Hospital)
Kang, Jeong Eun (Department of Pathology, Yonsei University Severance Hospital)
Won, Jun Ho (Department of Pathology, Daehang Hospital)
Publication Information
Korean Journal of Clinical Laboratory Science / v.53, no.2, 2021 , pp. 174-187 More about this Journal
Abstract
Cytotechnologists evaluate and analyze disorders of cells that constitute the human body, and are involved in the primary assessment of diverse diseases, including cancer. However, the employment conditions and workload of cytotechnologists are poorly understood. This study was undertaken to provide basic data for establishing the criteria for quality control certification factors based on the scope of effective task performance of cytotechnologists, and to provide results of their workload analysis according to the type of medical institution. The study was conducted by enrolling certified cytotechnologists working at various nationwide medical institutions. Our analysis revealed that 178 personnel (72.7%) were involved in primary screening of samples. On an average, the daily number of primary screening of samples performed per cytotechnologist (76 respondents) was determined to be 75.4 chapters (16.8 chapters/hours) at the university hospital level, 72.4 chapters (18.6 chapters/hours) at the general hospital level, and 231 chapters (32.6 chapters/hours) at professional trust institutions. Our results indicate the necessity to establish a consultant with the Korean Cell Pathology Association, to enable finding solutions to solve existing issues by establishing accurate standard guidelines for assessing cell screening.
Keywords
Cytotechnologist; Primary screening; Workload;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee KW, Song JY. Epidemiology of cervical cancer. J Korean Med Assoc. 2007;50:762-768.   DOI
2 National Cancer Information Center (NCIC). Cancer incidence trend analysis in 1999-2018 [Internet]. Gyeonggi: National Cancer Information Center; 2021 [cited by 2021 March 31]. Available from: https://www.cancer.go.kr/
3 Ministry of Health and Welfare (MOHW). Reduced cancer incidence for 4 consecutive years and cancer survival rate increased [Internet]. Sejong: Ministry of Health and Welfare; 2017 [cited by 2021 March 31]. Available from: https://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&CONT_SEQ=343242&page=1
4 Korean Statistical Information Service (KOSIS). State of the national examination and judgment of cervical cancer [Internet]. Daejeon: Korean Statistical Information Service; 2021 [cited by 2021 March 31]. Available from: https://kosis.kr/statisticsList/statisticsListIndex.do?vwcd=MT_ZTITLE&menuId=M_01_01#content-group.
5 Park JH, Ha SY, Cho HY, Chung DH, Kim NR, Park SH. The usefulness of cervicovaginal cytology as a primary screening test. Korean J Cytopathol. 2008;19:107-110.   DOI
6 Lee SH, Kim DW, Kang MJ, Kim EH, Jung JE, Han SW. A comparative analysis of cervical cancer preventive effect after treatment of cervical precanceous lesions (NHIMC 2015-20-020). National Health Insurance Service Ilsan Hospital. 2015;1-99.
7 Kimberlin DW, Brady MT, Jackson MA, ed. Red book 2018 [Internet]. 31th. Illinois (IL): American Academy of Pediatrics; 2018 [cieted by 2021 March 31] Available from: https://ebooks.aappublications.org/content/red-book-2018
8 Wiener HG, Klinkhamer P, Schenck U, Arbyn M, Bulten J, Bergeron C, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories. Cytopathology. 2007;18:67-78. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2303.2007.00451.x   DOI
9 Canadian Society of Cytopathology. Canadian society of cytopathology Guidelines for practice and quality assurance in cytopathology [Internet]. Canadian Society of Cytopathology; 2019 [cited by 2021 March 31]. Available from: https://cytopathology.ca/wp-content/uploads/2019/04/CSC-cyto_guidelines-final-2019.-docx.pdf.
10 Kim HS, Kwon PS, Kang JH, Yang MG, Park JO, Kim DJ, et al. Survey on the education system and national licensing examination for fostering competent medical technologists. Korean J Clin Lab Sci 2017;49:161-170. https://doi.org/10.15324/kjcls.2017.49.2.161   DOI
11 Centers for Disease Control and Prevention (CDC). Clinical laboratory improvement amendments fo 1988 [Internet]. Atlanta: Center for Disease Control and Prevention; 2018 [cited by 2021 March 31]. Available from: https://www.cdc.gov/clia/index.html
12 Australian Institute of Health and Welfare. Cervical screening in Australia 2014-2015 [Internet]. Canberra: Australian Institute of Health and Welfare; 2015 [cited by 2021 March 31]. Available from: https://www.aihw.gov.au/getmedia/adc621ce-a54a-4680-8b37-2a70d897964a/20434.pdf.aspx?inline=trueovernment Department of Health, Commonwealth of Australia 2014.